Literature DB >> 21295492

Environmental influences on T regulatory cells in inflammatory bowel disease.

Gijs Hardenberg1, Theodore S Steiner, Megan K Levings.   

Abstract

Inflammatory bowel disease (IBD) is characterized by chronic, idiopathic inflammation of the intestine. The disease is thought to result from a combination of genetic and environmental factors which ultimately leads to a mucosal immune system that overreacts to normal constituents of the mucosal microbiota. The inflammation in IBD is primarily mediated by inappropriate production of proinflammatory cytokines by CD4(+) T effector cells, effects that are suppressed by CD4(+) T regulatory cells. Defects in both the function of T regulatory cells, and the ability of T effector cells to be suppressed, have been implicated in IBD. In this review we will discuss environmental factors, including cytokines, vitamins A and D, and commensal bacteria, which influence the phenotype and function of regulatory T cells and thereby alter the course of IBD. We will also discuss how these environmental signals can be manipulated therapeutically in order to improve the function of regulatory T cells and ultimately restore mucosal homeostasis in patients with IBD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295492     DOI: 10.1016/j.smim.2011.01.012

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  14 in total

Review 1.  Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers.

Authors:  Megan E Himmel; Yu Yao; Paul C Orban; Theodore S Steiner; Megan K Levings
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 2.  Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians.

Authors:  Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2018-05-08       Impact factor: 2.638

Review 3.  Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance.

Authors:  Hanyu Zeng; Rong Zhang; Boquan Jin; Lihua Chen
Journal:  Cell Mol Immunol       Date:  2015-06-08       Impact factor: 11.530

4.  IRF1 and BATF: key drivers of type 1 regulatory T-cell differentiation.

Authors:  Sophia Giang; Antonio La Cava
Journal:  Cell Mol Immunol       Date:  2017-06-19       Impact factor: 11.530

Review 5.  Induced and natural regulatory T cells in the development of inflammatory bowel disease.

Authors:  Christopher G Mayne; Calvin B Williams
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

6.  Reversing Ongoing Chronic Intestinal Inflammation and Fibrosis by Sustained Block of IL-12 and IL-23 Using a Vaccine in Mice.

Authors:  Qingdong Guan; Carolyn R Weiss; Shuhe Wang; Gefei Qing; Xi Yang; Richard J Warrington; Charles N Bernstein; Zhikang Peng
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

7.  Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice.

Authors:  Zhenglei Xu; Cheng Wei; R U Zhang; Jun Yao; Dinguo Zhang; Lisheng Wang
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

Review 8.  Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease.

Authors:  Yaron Ilan
Journal:  Clin Transl Immunology       Date:  2016-01-29

9.  Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.

Authors:  Xiaohua Wang; Jintao Zhang; David J Baylink; Chih-Huang Li; Douglas M Watts; Yi Xu; Xuezhong Qin; Michael H Walter; Xiaolei Tang
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

10.  FoxP3⁺ regulatory T cells attenuate experimental necrotizing enterocolitis.

Authors:  Bridgette M Dingle; Yuying Liu; Nicole Y Fatheree; Juleen Min; J Marc Rhoads; Dat Q Tran
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.